<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39374708</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-2939</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Oct</Month><Day>05</Day></PubDate></JournalIssue><Title>The Journal of hospital infection</Title><ISOAbbreviation>J Hosp Infect</ISOAbbreviation></Journal><ArticleTitle>Efficacy of Air Cleaning Units for preventing SARS-CoV-2 and other hospital-acquired infections on medicine for older people wards: A quasi-experimental controlled before-and- after study.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">S0195-6701(24)00325-6</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jhin.2024.09.017</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Nosocomial infections are costly and airborne transmission is increasingly recognised as important for spread. Air Cleaning Units (ACUs) may reduce transmission but little research has focused on their effectiveness on open wards.</AbstractText><AbstractText Label="AIM" NlmCategory="OBJECTIVE">Assess whether ACUs reduce nosocomial SARS-CoV-2, or other, infections on older adult inpatient wards.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Quasi-experimental before-after study on two intervention-control ward pairs in a UK teaching hospital. Infections were identified using routinely collected electronic health records data during one year of ACU implementation and the preceding year ("core study period"). Extended analyses included 6 months additional data from one ward pair following ACU removal. Hazard ratios (HR) were estimated through Cox regression controlling for age, sex, ward and background infection risk. Time the ACUs were switched on was also recorded for intervention ward 2.</AbstractText><AbstractText Label="FINDINGS" NlmCategory="RESULTS">ACUs were initially feasible but compliance reduced towards the end of the study (average operation in first vs second half of ACU time on intervention ward 2: 77% vs 53%). 8171 admissions &gt;48hrs (6112 patients, median age 85yrs) were included. Overall, incidence of ward-acquired SARS-CoV-2 was 3.8%. ACU implementation was associated with a non-significant trend of lower hazard for SARS-CoV-2 infection (HR core study period 0.90, 95% CI 0.53, 1.52; extended study period 0.78, 95% CI 0.53, 1.14). Only 1.5% of admissions resulted in other notable ward-acquired infections.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">ACUs may reduce SARS-CoV-2 infection to a clinically-meaningfully degree. Larger studies could reduce uncertainty, perhaps using a cross-over design, and factors influencing acceptability to staff and patients should be further explored.</AbstractText><CopyrightInformation>Copyright Â© 2024. Published by Elsevier Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Brock</LastName><ForeName>Rebecca C</ForeName><Initials>RC</Initials><AffiliationInfo><Affiliation>MRC Biostatistics Unit, School of Clinical Medicine, University of Cambridge, Cambridge. UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goudie</LastName><ForeName>Robert J B</ForeName><Initials>RJB</Initials><AffiliationInfo><Affiliation>MRC Biostatistics Unit, School of Clinical Medicine, University of Cambridge, Cambridge. UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peters</LastName><ForeName>Christine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Microbiology, NHS Greater Glasgow and Clyde, Glasgow, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thaxter</LastName><ForeName>Rachel</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Infection Control, Cambridge University Hospitals, Cambridge. UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gouliouris</LastName><ForeName>Theodore</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Cambridge University Hospitals, Cambridge. UK; Department of Medicine, School of Clinical Medicine, University of Cambridge, Cambridge. UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Illingworth</LastName><ForeName>Christopher J R</ForeName><Initials>CJR</Initials><AffiliationInfo><Affiliation>MRC-University of Glasgow Centre for Virus Research, Glasgow.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morris</LastName><ForeName>Andrew Conway</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Department of Medicine, School of Clinical Medicine, University of Cambridge, Cambridge. UK; The John Farman ICU, Cambridge University Hospitals, Cambridge. UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beggs</LastName><ForeName>Clive B</ForeName><Initials>CB</Initials><AffiliationInfo><Affiliation>Carnegie School of Sport, Headingley Campus, Leeds Beckett University, Leeds, UK; Department of Medicine for the Elderly, Cambridge University Hospitals, Cambridge. UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Butler</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medicine for the Elderly, Cambridge University Hospitals, Cambridge. UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Keevil</LastName><ForeName>Victoria L</ForeName><Initials>VL</Initials><AffiliationInfo><Affiliation>Department of Medicine, School of Clinical Medicine, University of Cambridge, Cambridge. UK; Department of Medicine for the Elderly, Cambridge University Hospitals, Cambridge. UK. Electronic address: v.keevil@nhs.net.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Hosp Infect</MedlineTA><NlmUniqueID>8007166</NlmUniqueID><ISSNLinking>0195-6701</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Air Cleaning Units</Keyword><Keyword MajorTopicYN="N">Infection Prevention and Control</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">airborne</Keyword><Keyword MajorTopicYN="N">hospital acquired infection</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest CB is an expert witness in Module 3 of the UK Covid-19 Inquiry, and has received financial remuneration for his work in this capacity. MB and CP have undertaken work for FreshAirNHS, a non-profit campaigning organisation advocating for airborne mitigations within the NHS, they have not received any financial remunerations for this work. ACM sits on the scientific advisory board of Cambridge Infection Diagnostics and has received speaking fees from Biomerieux, Fischer and Paykel, ThermoFisher and Boston Scientific.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>8</Day><Hour>4</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>8</Day><Hour>4</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>7</Day><Hour>19</Hour><Minute>13</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39374708</ArticleId><ArticleId IdType="doi">10.1016/j.jhin.2024.09.017</ArticleId><ArticleId IdType="pii">S0195-6701(24)00325-6</ArticleId></ArticleIdList></PubmedData></PubmedArticle>